Characterization of the AT180 epitope of phosphorylated Tau protein by a combined nuclear magnetic resonance and fluorescence spectroscopy approach

Biochemical and Biophysical Research Communications

Volumn 412, Issue 4, 2011, Pages 743-746

  Amniai, Laziza ^a   Lippens, Guy ^a   Landrieu, Isabelle ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Epitope mapping; Fluorescence spectroscopy; Monoclonal antibody; Nuclear magnetic resonance spectroscopy; Phosphorylation; Tau protein

Indexed keywords

ARGININE; CYSTEINE; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AT180; RECOMBINANT PROTEIN; SERINE; TAU PROTEIN; THREONINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; DISSOCIATION CONSTANT; EPITOPE MAPPING; FLUORESCENCE SPECTROSCOPY; FORSTER RESONANCE ENERGY TRANSFER FLOURESCENCE SPECTROSCOPY; MUTAGENESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE;

ANTIBODIES, MONOCLONAL; EPITOPES; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MUTATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RECOMBINANT PROTEINS; TAU PROTEINS;

EID: 80052638024     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.046     Document Type: Article

References (13)

1. Goedert M., Jakes R., Crowther R.A., Cohen P., Vanmechelen E., Vandermeeren M., Cras P. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J. 1994, 301(Pt 3):871-877.
2. Bertrand J., Senechal P., Zummo-Soucy M., Plouffe V., Leclerc N. The formation of tau pathological phospho-epitopes in the axon is prevented by the dephosphorylation of selective sites in primary hippocampal neurons over-expressing human tau. J. Neurochem. 2010, 114:1353-1367.
3. Hamdane M., Sambo A.V., Delobel P., Begard S., Violleau A., Delacourte A., Bertrand P., Benavides J., Buee L. Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. J. Biol. Chem. 2003, 278:34026-34034.
4. Cho J.H., Johnson G.V. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J. Biol. Chem. 2004, 279:54716-54723.
5. Landrieu I., Leroy A., Smet-Nocca C., Huvent I., Amniai L., Hamdane M., Sibille N., Buee L., Wieruszeski J.M., Lippens G. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease. Biochem. Soc. Trans. 2010, 38:1006-1011.
6. Jicha G.A., Lane E., Vincent I., Otvos L., Hoffmann R., Davies P. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J. Neurochem. 1997, 69:2087-2095.
7. Sasakawa H., Sakata E., Yamaguchi Y., Masuda M., Mori T., Kurimoto E., Iguchi T., Hisanaga S., Iwatsubo T., Hasegawa M., Kato K. Ultra-high field NMR studies of antibody binding and site-specific phosphorylation of alpha-synuclein. Biochem. Biophys. Res. Commun. 2007, 363:795-799.
8. De Genst E.J., Guilliams T., Wellens J., O'Day E.M., Waudby C.A., Meehan S., Dumoulin M., Hsu S.T., Cremades N., Verschueren K.H., Pardon E., Wyns L., Steyaert J., Christodoulou J., Dobson C.M. Structure and properties of a complex of alpha-synuclein and a single-domain camelid antibody. J. Mol. Biol. 2010, 402:326-343.
9. Amniai L., Barbier P., Sillen A., Wieruszeski J.M., Peyrot V., Lippens G., Landrieu I. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules. FASEB J. 2009, 23:1146-1152.
10. Lippens G., Wieruszeski J.M., Leroy A., Smet C., Sillen A., Buee L., Landrieu I. Proline-directed random-coil chemical shift values as a tool for the NMR assignment of the tau phosphorylation sites. Chembiochem 2004, 5:73-78.
11. Smet C., Leroy A., Sillen A., Wieruszeski J.M., Landrieu I., Lippens G. Accepting its random coil nature allows a partial NMR assignment of the neuronal Tau protein. Chembiochem 2004, 5:1639-1646.
12. Landrieu I., Smet-Nocca C., Amniai L., Louis J.V., Wieruszeski J.M., Goris J., Janssens V., Lippens G. Molecular Implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of Tau. PLoS One 2011, 6:e21521.
13. N. Sibille, I. Huvent, C. Fauquant, D. Verdegem, L. Amniai, A. Leroy, J.M. Wieruszeski, G. Lippens, I. Landrieu, Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline-rich region of the disordered Tau protein (unpublished results).